Stock AGP AGP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials AGP Limited

Equities

AGP

PK0113801010

Pharmaceuticals

End-of-day quote Pakistan S.E.
Other stock markets
 23:00:00 27/06/2024 BST 		5-day change 1st Jan Change
92.37 PKR +3.21% Intraday chart for AGP Limited +2.33% +31.38%
04-30 AGP Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-29 AGP Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 24,480 27,818 31,886 27,157 18,197 19,687
Enterprise Value (EV) 1 26,283 28,909 32,557 29,556 21,160 31,282
P/E ratio 20.3 x 19.2 x 20.1 x 15.5 x 11.6 x 12.6 x
Yield 1.43% 3.27% 1.76% 2.58% 3.08% 3.56%
Capitalization / Revenue 4.55 x 4.45 x 4.59 x 2.91 x 1.26 x 1.05 x
EV / Revenue 4.88 x 4.62 x 4.69 x 3.17 x 1.46 x 1.67 x
EV / EBITDA 15 x 13.2 x 14.7 x 11.2 x 6.6 x 6.82 x
EV / FCF 74 x 38.7 x 37.3 x -13 x -531 x -3.79 x
FCF Yield 1.35% 2.58% 2.68% -7.69% -0.19% -26.4%
Price to Book 3.84 x 3.73 x 3.88 x 2.81 x 1.73 x 1.72 x
Nbr of stocks (in thousands) 280,000 280,000 280,000 280,000 280,000 280,000
Reference price 2 87.43 99.35 113.9 96.99 64.99 70.31
Announcement Date 26/03/19 14/04/20 05/04/21 24/03/22 22/03/23 29/02/24
1PKR in Million2PKR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 5,382 6,253 6,946 9,317 14,459 18,743
EBITDA 1 1,757 2,192 2,217 2,638 3,208 4,588
EBIT 1 1,653 2,066 2,080 2,470 2,969 4,285
Operating Margin 30.72% 33.04% 29.94% 26.51% 20.54% 22.86%
Earnings before Tax (EBT) 1 1,426 1,825 1,927 2,308 2,441 2,635
Net income 1 1,207 1,446 1,587 1,747 1,570 1,565
Net margin 22.42% 23.13% 22.85% 18.75% 10.86% 8.35%
EPS 2 4.310 5.166 5.669 6.240 5.607 5.590
Free Cash Flow 1 355 747.2 873.8 -2,273 -39.85 -8,245
FCF margin 6.6% 11.95% 12.58% -24.39% -0.28% -43.99%
FCF Conversion (EBITDA) 20.21% 34.09% 39.41% - - -
FCF Conversion (Net income) 29.42% 51.66% 55.05% - - -
Dividend per Share 2 1.250 3.250 2.000 2.500 2.000 2.500
Announcement Date 26/03/19 14/04/20 05/04/21 24/03/22 22/03/23 29/02/24
1PKR in Million2PKR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 1,803 1,091 671 2,398 2,962 11,595
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.026 x 0.4977 x 0.3027 x 0.9091 x 0.9234 x 2.527 x
Free Cash Flow 1 355 747 874 -2,273 -39.9 -8,245
ROE (net income / shareholders' equity) 20.3% 20.9% 20.3% 20.1% 16% 15.5%
ROA (Net income/ Total Assets) 11.8% 13.9% 13.1% 12.3% 11.8% 12%
Assets 1 10,211 10,398 12,087 14,181 13,288 13,006
Book Value Per Share 2 22.70 26.70 29.30 34.60 37.70 40.90
Cash Flow per Share 2 0.0900 0.4200 1.320 1.630 0.7700 0.7200
Capex 1 337 433 364 481 933 734
Capex / Sales 6.26% 6.93% 5.25% 5.16% 6.45% 3.92%
Announcement Date 26/03/19 14/04/20 05/04/21 24/03/22 22/03/23 29/02/24
1PKR in Million2PKR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
AGP LIMITED Stock AGP Limited
+31.38% 92.93M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+44.05% 641B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 314B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 242B
NOVARTIS AG Stock Novartis AG
+13.31% 218B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
PFIZER, INC. Stock Pfizer, Inc.
-2.81% 159B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AGP Stock
  4. Financials AGP Limited